Mark Leonard Singleton - Mar 24, 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & CFO
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Mar 24, 2023
Transactions value $
-$7,676
Form type
4
Date filed
3/27/2023, 07:27 PM
Previous filing
Mar 23, 2023
Next filing
Apr 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Sale -$7.68K -6.04K -32.45% $1.27 12.6K Mar 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover taxes upon the vesting of restricted stock units on March 21, 2023 pursuant to a standing Rule 10b5-1 instruction provision in the award agreement, dated March 21, 2022.